In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumour
- 28 February 1995
- journal article
- Published by Elsevier in Surgical Oncology
- Vol. 4 (1) , 41-49
- https://doi.org/10.1016/s0960-7404(10)80030-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.Proceedings of the National Academy of Sciences, 1995
- Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogeneCellular Immunology, 1993
- HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen PresentationScience, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985